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The Neonatal Screening for Inborn Errors of Metabolism of the Association of Parents and Friends of Special Needs Individuals (APAE) - Bauru, Brazil, was implanted and 
accredited by the Brazilian Ministry of Health in 1998.  It covers about 286 cities of the 
Bauru region and 420 collection spots. Their activities include screening, diagnosis, treat-
ment and assistance to congenital hypothyroidism (CH) and phenylketonuria (PKU), among 
others. In 2005, a partnership was established with the Department of Speech-Language 
Pathology and Audiology, Bauru School of Dentistry, University of São Paulo, Bauru, se-
eking to characterize and to follow, by means of research studies, the development of the 
communicative abilities of children with CH and PKU. Objective: The aim of this study was 
to describe communicative and psycholinguistic abilities in children with CH and PKU. Ma-
terials and Methods: Sixty-eight children (25 children aged 1 to 120 months with PKU and 
43 children aged 1 to 60 months with CH) participated in the study. The handbooks were 
analyzed and different instruments were applied (Observation of Communication Behavior, 
Early Language Milestone Scale, Peabody Picture Vocabulary Test, Gesell & Amatruda’s 
Behavioral Development Scale, Portage Operation Inventory, Language Development Evalu-
ation Scale, Denver  Developmental Screening Test, ABFW Child Language Test-phonology 
and Illinois Test of Psycholinguistic Abilities), according to the children’s age group and 
developmental level. Results: It was observed that the children with PKU and CH at risk 
for alterations in their developmental abilities (motor, cognitive, linguistic, adaptive and 
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hyperactivity and alterations in the personal-social, language and motor adaptive abilities 
were more frequent in children with PKU. Conclusion: CH and PKU can cause communicative 
and psycholinguistic alterations that compromise the communication and affect the social 
integration and learning of these individuals, proving the need of having these abilities 
assisted by a speech and language pathologist.
Key words: Phenylketonurias. Congenital hypothyroidism. Communication. Child.
www.scielo.br/jaos
2009; 17(sp. issue):69-75
J Appl Oral Sci. 70
INTRODUCTION 
Neonatal screening program (NSP) is the 
popular name attributed to the Neonatal 
Screening for Inborn Errors of Metabolism, which 
has the objective of detecting early congenital 
hypothyroidism (CH) and phenylketonuria 
(PKU), among other alterations that can cause 
			7.
The NSP of the Association of Parents and 
Friends of Special Needs Individuals/Bauru 
(APAE-Bauru) was implanted and accredited by 
Brazilian Ministry of Health in 1998. It covers 
approximately 286 cities of the Bauru area, 
totalizing 420 collection spots. Their activities 
include screening, diagnosis and long-term 
assistance for CH and PKU. The multidisciplinary 
team for the assistance to the individuals is 
composed by a pediatrician, an endocrinologist, a 
nutritionist, a psychologist, a neurologist, a social 
assistant, a speech language pathologist and a 
biochemist. This is a pioneering work in this area 
because the speech language pathologist is not 
included in the team of professionals proposed by 
the Ministry Health. However, studies have shown 
communicative, psycholinguistic, cognitive, 
motor and personal-social developmental 
alterations, even in children with early beginning 
of treatment3,5,10,15,18,22,25,27-29. 
CH is a systemic metabolic disturbance 
caused by insufficient production of thyroid 
hormones due to thyroid gland malformation or 
alterations in hormonal biosyntheses20,21. These 
   !   	
nervous system (CNS) development because the 
vascularization, myelinization, dendritic trees, 
synapse formation, neuronal migration and 
genes expression depend on them3,22-25. 
PKU is an autosomal recessive disorder, 
resulting from the mutation of the gene located 
in chromosome 12q22-24.16. PKU is caused by 
the lack of an enzyme known as phenylalanine 
hydroxylase. This enzyme is responsible for 
converting the amino acid phenylalanine to a 
second amino acid, tyrosine, in the liver27. The 
alterations found in the brain tissue of individuals 
"#$
and might compromise the CNS maturation, 
!	%
in the biochemical processes that affect some 
neurotransmitters. 
The objective of this study was to describe 
communicative and psycholinguistic abilities in 
children with CH and PKU.
MATERIAL AND METHODS
After approval by the Research Ethics 
Committee (Protocol #14/2005) of the Bauru 
School of Dentistry, University of São Paulo, the 
parents were asked to sign an informed consent 
form according to 196/96 Resolution. The study 
was developed in partnership with one of the six 
São Paulo State NSP centers, accredited by the 
Ministry of Health.
The criteria for the participants’ eligibility 
were: having early diagnosis7 for CH (TSH above 
10 μIU/mL and T4 free below 0.75 mg/dL) or for 
PKU7,9 (PHE levels above 4 mg/dL); attending 
periodic follow up according to the national 
guidelines1; not presenting other congenital or 
acquired alterations apart from those of CH and/
or PKU; being aged less than 120 months for PKU 
and 60 months for CH.
Sixty-eight individuals of both genders aged 1 
to 120 months were enrolled, being 25 children in 
the PKU group (PKUG) and 43 children in the CH 
group (CHG). The clinical history was collected 
by review of the medical records. The following 
evaluation instruments were used according to 
the age group:
*Early Language Milestone Scale11 (ELMS): 
to evaluate the visual, receptive auditory and 
expressive auditory functions of children under 
36 months of age.
*Peabody Picture Vocabulary Test12 (PPVT): 
to evaluate the receptive vocabulary of children 
over 36 months of age.
*Gesel l  and Amatruda ’s Behaviora l 
Development Scale17 (GABDS): to evaluate 
      
language and personal-social behavior of children 
under 72 months of age.
*Portage Operation Inventory30 (POI): 
to evaluate the motor, language, cognition, 
socialization and self-car behavior of children 
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under 72 months of age.
*Language Development Evaluation Scale21 
(LDES): to evaluate the receptive and expressive 
language development of children under 83 
months of age.
*Denver Developmental Screening Test13 
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motor, gross motor, language and personal-social 
behavior of children under 72 months of age.
*ABFW Child Language Test-phonology2 – 
(ABFW): to evaluate the phonology of children 
over 36 months of age. 
*Illinois Test of Psycholinguistic Abilities4 
(ITPA): to evaluate the 12 psycholinguistic 
abilities subtests of children over 36 months 
of age (auditory reception, visual reception, 
auditory association, visual association, auditory 
memory, visual memory, auditory closure, visual 
closure, grammatical closure, verbal expression, 
manual expression, sounds combination).
*Observation of Communication Behavior 
(OCB): to evaluate the communicative function, 
comprehension, dialogue maintenance, symbolic 
play and time attention in all children of the 
study. 
Descriptive statistical analysis was used in 
the results obtained for the CHG and PKUG. 
The Spearman’s correlation test was used 
to determine the correlations among the 
	
level of 5% was set for all analyses.
RESULTS
 
Figure 1 presents, in percentage, the results 
of the alterations in the abilities evaluated in the 
DDST-II of 43 children with CH and 17 children 
with PKU.
Figure 2 presents, in percentage, the results 
of the alterations in the abilities evaluated in 
the POI of 43 children with CH and 17 children 
with PKU.
Figure 3 presents, in percentage, the results 
of the alterations in the abilities evaluated in the 
GABDS of 43 children with CH and 17 children 
with PKU.
Figure 4 presents, in percentage, the results 
of the alterations in the abilities evaluated in the 
ELMS (expressive auditory, receptive auditory 
and visual) of 35 children with CH and 12 children 
with PKU; in the LDES of 43 children with CH and 
17 with PKU; in the PPVT of 8 children with CH 
and 13 with PKU; and in the ABFW of 8 children 
with CH and 13 with PKU.
Figure 5 presents, in percentage, the results 
of the alterations in the abilities evaluated in the 
ITPA of 12 children with CH and 15 with PKU.
In the OCB, the CHG and PKUG presented 
verbal order comprehension, protesting, 
requesting, offering and informing functions, 
and symbolic play allowing dialogical activities. In 
		
in attention time maintenance (39.5% for CHG 
and 64% for PKUG). The PKUG also presented 
Figure 1- Percentage of children with alterations in the abilities of the DDST-II
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Figure 3- Percentage of children with alterations in the abilities of the GABDS
Figure 4- Percentage of children with alterations in the abilities of the ELMS, LDES, PPVT and ABFW
Figure 2- Percentage of children with alterations in the abilities of the POI
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by the review of the clinical history.
>			
among the evaluation instruments, which means 
that the instruments used in the study had 
similar capacity to evaluate the same ability.
DISCUSSION
Analyzing the Figures 1 to 3, the CHG 
presented worse performance in the language 
area and PKUG in the personal-social area, 
			

areas. The literature refers that delays in the oral 
language acquisition are frequent in CH3,15,24 and 
that individuals with PKU are of risk for alterations 
in their personal-social5, psycholinguistic10,22,29 
14 abilities. Few works 
			28. The language 
is a superior mental function, which depends 
on the CNS integrity, sensorial, perceptual, 
cognitive and maturational processes, and the 
!15>		
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
been emphasized. In other words, the language 
is the mediator for the child planing actions 
and interacting with the social environment. 
Therefore, alterations in the receptive or 
expressive language performance affect other 
	 	 	   
personal-social skills, interfere in the language 
development. As far as the expressive aspects 
are concerned (ELMS, LDES, ABFW, ITPA-verbal 
expression), CHG and PKUG did not present 
		
the language use.
It has been reported that the longer the period 

more severe and more extensive the cerebral 
damages because there will be alterations in 
the neuronal connections reducing the stimulus 
transmission capacity3,18,20,24. Individuals who 
cannot maintain the recommended phenylalanine 
levels can present alterations in the chemical 
mechanisms of the solid neurotransmitters with 
pre-frontal and/or left hemisphere dysfunction29, 
which affects the general learning.
Comparing the performance of CHG and 
PKUG in PPVT and LDES (Figure 4), PKUG 
presented more extensive damages. These data 
=Z	
test, proving that children that failed in one of 
the tests, in a given ability, also failed in the 
correlated abilities in another test. It means that 
these instruments were sensitive to detect the 
		
hypothesis. It is emphasized that CH treatment 
is accomplished by hormonal replacement7,19,23,24, 
Figure 5- Percentage of children with alterations in the abilities of the ITPA
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while PKU treatment involves a phenylalanine-
poor diet3,5-7,10,16,27, making PKU control much 
more complex, especially in older children.
In ITPA, the most extensive damages were 
observed in CHG compared to PKUG. In OCB, 
difficulty was verified in the attention time 
maintenance for CHG and PKUG, which also 
presented hyperactivity. It is inferred that the 
	?>"!	
in the attention time maintenance. These 
symptoms have been extensively discussed 
in the literature1,3,8,14,18,25-26. In other words, 
   	 
hyperactivity are observed in CH3,20,25 and 
PKU1,14,22,28, and brings interference in attention, 
concentration, memory, analysis, synthesis 
abilities and executive functions performance, 
which depends on the appropriate CNS operation.
In this study, measurement of TSH, T4 and 
phenylalanine levels was done periodically during 
the treatment and the values were not correlated. 
Neurological imaging exams were also performed 
during the course of the treatment. These 
analyses are objective of future studies.
With the exposed so far, it is inferred that 
the treatment accomplished by the SNP in 
	["#$[ 
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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		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   
prevention of alterations in the communicative 
and psycholinguistic abilities that compromise 
the communication and interfere in the social 
integration and learning, indicating the need 
of assistance for these abilities by a speech 
language pathologist.
CONCLUSION
In the studied population, children with CH and 
PKU presented alterations in their developmental 
	 +	 	
	  
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visual and auditory psycholinguistic abilities of 
school children. The importance of having these 
children assisted is emphasized, seeking the 
prevention of communicative and psycholinguistic 
alterations as well as the increase of their social 
integration in the family and school environment.
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